<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Infect. Dis</journal-id>
    <journal-title-group>
      <journal-title>BMC Infectious Diseases</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2334</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6542142</article-id>
    <article-id pub-id-type="publisher-id">4123</article-id>
    <article-id pub-id-type="doi">10.1186/s12879-019-4123-z</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DisV-HPV16, versatile and powerful software to detect HPV in RNA sequencing data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Yan</surname>
          <given-names>Bingqing</given-names>
        </name>
        <address>
          <email>ybq1204@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Xinyi</given-names>
        </name>
        <address>
          <email>lchengy1988@163.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Siwei</given-names>
        </name>
        <address>
          <email>664382528@qq.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Siyang</given-names>
        </name>
        <address>
          <email>yusiyangnikki@163.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tong</surname>
          <given-names>Fangjia</given-names>
        </name>
        <address>
          <email>tfjviki@hotmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Huanhuan</given-names>
        </name>
        <address>
          <email>1312830035@qq.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Song</surname>
          <given-names>Lianhao</given-names>
        </name>
        <address>
          <email>2743623823@qq.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yan</given-names>
        </name>
        <address>
          <email>zhangtyo@hit.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wei</surname>
          <given-names>Lanlan</given-names>
        </name>
        <address>
          <email>weilanlan@hrbmu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2204 9268</institution-id><institution-id institution-id-type="GRID">grid.410736.7</institution-id><institution>College of Basic Medicine, </institution><institution>Harbin Medical University, </institution></institution-wrap>Harbin, 150081 China </aff>
      <aff id="Aff2"><label>2</label>Wu Lien-Ten Institute, Harbin, 150081 China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0193 3564</institution-id><institution-id institution-id-type="GRID">grid.19373.3f</institution-id><institution>College of Life Sciences, Harbin Institute of Technology, </institution></institution-wrap>Harbin, 150081 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>29</day>
      <month>5</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>5</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>19</volume>
    <elocation-id>479</elocation-id>
    <history>
      <date date-type="received">
        <day>31</day>
        <month>12</month>
        <year>2018</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>5</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s). 2019</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The increasing availability of high-throughput sequencing data provides researchers with unprecedented opportunities to investigate viral genetic elements in host genomes that contribute to virus-linked cancers. Almost all of the available computational tools for secondary analysis of sequencing data detect viral infection or genome integration events. However, viral oncogenes expression is likely of importance in carcinoma. We therefore developed a new software, DisV-HPV16, for the evaluation of HPV16 oncogenes expression.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">HPV16 virus and viral oncogenes expression was detected more rapidly using DisV-HPV16 compared to other software. DisV-HPV16 was proved highly convenient for detecting candidate virus after modification of the reference file. The accuracy of DisV-HPV16 was empirically confirmed in laboratory experiments. DisV-HPV16 exhibited greater reliability than other software.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">DisV-HPV16 is a new, dependable software to detect virus and viral oncogenes expression through analysis of RNA sequencing data. Use of DisV-HPV16 can yield deeper, more comprehensive insights into virus infection status and viral and host cell gene expression.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>HPV16 oncogenes</kwd>
      <kwd>Software</kwd>
      <kwd>RNA sequencing</kwd>
      <kwd>Virus</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Natural Science Foundation of China </institution>
        </funding-source>
        <award-id>81672670</award-id>
        <award-id>81501737</award-id>
        <principal-award-recipient>
          <name>
            <surname>Wei</surname>
            <given-names>Lanlan</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Heilongjiang province outstanding youth foundation</institution>
        </funding-source>
        <award-id>jc2018023</award-id>
        <principal-award-recipient>
          <name>
            <surname>Wei</surname>
            <given-names>Lanlan</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2019</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par8">The number of cancer patients has reportedly increased in recent years. It is estimated that there were 14.9 million incident cancer cases and 8.2 million cancer deaths worldwide in 2013 [<xref ref-type="bibr" rid="CR1">1</xref>]. Approximately 10–15% of human cancers are known to be caused by viruses [<xref ref-type="bibr" rid="CR2">2</xref>]. Human papillomavirus (HPV) is a sexually transmitted virus causing various benign and malignant diseases including condyloma acuminatum [<xref ref-type="bibr" rid="CR3">3</xref>], cervical carcinoma(CC) and head and neck squamous carcinoma (HNSC) [<xref ref-type="bibr" rid="CR4">4</xref>]. Since the first detection by Gissmann in 1982 [<xref ref-type="bibr" rid="CR5">5</xref>], the presence of human papillomavirus (HPV) in tumor tissue samples from the head and neck, especially oropharyngeal carcinoma, has been increasing worldwide [<xref ref-type="bibr" rid="CR6">6</xref>]. The HPV family consists of at least 170 different virus types that preferentially infect the mucosa of the genitals [<xref ref-type="bibr" rid="CR7">7</xref>]. The high-risk HPV type, a sub-group of mucosal HPVs, causes approximately 5% of all human cancers, corresponding to one-third of all virus-induced tumors [<xref ref-type="bibr" rid="CR8">8</xref>]. Within the high-risk HPV group, HPV16 is the most oncogenic type found in HNSC patients [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
    <p id="Par9">The detection of viruses in human cancer tissues has significant clinical implications in oncology. Widespread clinical application of next generation sequencing (NGS) and rapid advances in NGS technology in recent years have enhanced the capabilities for virus detection in human cells and enabled large-scale investigations of virus-host interactions [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. Several software tools have been developed including VirusSeq [<xref ref-type="bibr" rid="CR13">13</xref>], VirusFinder [<xref ref-type="bibr" rid="CR14">14</xref>] and ViromeScan [<xref ref-type="bibr" rid="CR15">15</xref>] that apply a computational subtraction algorithm to distinguish viruses within NGS data. VirusSeq and VirusFinder, however, are disadvantaged by extensive time and multiple alignment tools, respectively [<xref ref-type="bibr" rid="CR16">16</xref>]. Although ViromeScan is less time consuming than either VirusSeq or VirusFinder, it can only be used to determine the taxonomic composition of virome by aligning sequence reads to completely determined viral genomes [<xref ref-type="bibr" rid="CR15">15</xref>]. Furthermore, nearly all of the computational tools focus on detecting the presence and integration of virus in sequencing data [<xref ref-type="bibr" rid="CR17">17</xref>], which are considered the key factors in carcinogenesis [<xref ref-type="bibr" rid="CR18">18</xref>]. From a disease etiology perspective, however, the more important factor may be the expression of viral oncogenes.</p>
    <p id="Par10">HPV16 oncogenes including E5, E6 and E7 are known to contribute to carcinogenesis. E5 negatively regulates the TGF-β signaling pathway [<xref ref-type="bibr" rid="CR19">19</xref>]. E6 degrades p53 after binding to both p53 and E6-associated protein ligase [<xref ref-type="bibr" rid="CR20">20</xref>]. E7 binds to pRb and triggers expression of proteins necessary for DNA replication by activating the E2F transcription factor [<xref ref-type="bibr" rid="CR21">21</xref>]. Neither E6 nor E7 possess intrinsic enzymatic activity, but functions through direct and indirect interactions with host cellular proteins including several well-known tumor suppressors [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
    <p id="Par11">In light of the increasing incidence of HPV-associated HNSC, the severity of this disease and the roles of HPV E6 and E7 in carcinogenesis, we undertook the development of a new software tool to enable the detection and analysis of HPV16 oncogenes. The resulting DisV-HPV16 software detects HPV16 in RNA sequencing data and determines the expression levels of HPV16 oncogenes. DisV-HPV16 is faster, more sensitive and more accurate than other software tools. Moreover, its reliability was experimentally validated using RT-PCR.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <sec id="Sec3">
      <title>Data preparation</title>
      <p id="Par12">Human reference sequencing data were from UCSC build hg19/hg18 (<ext-link ext-link-type="uri" xlink:href="http://hgdownload.cse.ucsc.edu/downloads.html#human">http://hgdownload.cse.ucsc.edu/downloads.html#human</ext-link>). A file containing the entire genome sequence of HPV16, interrupted at the E1 gene initiation site (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a), was downloaded from the GEO database. We relocated the interruption site to position 7021 of the long coding region (LCR), thus producing modified sequencing data (in Fastq format) in which E6 initiates at position 104 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b) [<xref ref-type="bibr" rid="CR23">23</xref>]. HISAT2 was used to build reference files of human sequence and the modified HPV16 sequence. Meanwhile, an annotation file (in GTF format) of the modified HPV16 sequence was produced (containing E1, E2, E1^E4, E5, E6 and E7) with E6* added. Files of HPV18, HPV33 and HPV35 were similarly produced.<fig id="Fig1"><label>Fig. 1</label><caption><p>Whole genome sequence of HPV16. <bold>a</bold> Sequence information of HPV16 downloaded from GEO database initiated at the E1 gene site; <bold>b</bold> Modified sequence information of HPV16 with E6 relocated at position 104 in LCR</p></caption><graphic xlink:href="12879_2019_4123_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par13">RNA sequencing data from18 HPV-positive HNSC patients (HPV16, <italic>n</italic> = 14; HPV35, <italic>n</italic> = 2; HPV33, <italic>n</italic> = 1; HPV18, <italic>n</italic> = 1) were downloaded from GEO [<xref ref-type="bibr" rid="CR24">24</xref>]. The SRA Study identifier is SRP066090 (Runs: SRR2932830 to SRR2932847). RNA sequencing data of the SIHA cell line (Run: SRR1021009) and two HELA cell lines (Runs: SRR540252 and SRR629571) were also downloaded from GEO.</p>
    </sec>
    <sec id="Sec4">
      <title>Data processing</title>
      <p id="Par14">DisV-HPV16 input is raw single-end or pair-end reads in Fastq format, which can be mapped to a human reference genome using alignment tool HISAT [<xref ref-type="bibr" rid="CR25">25</xref>]. DisV-HPV16 garners all reads unmapped to the human reference genome for downstream analysis and aligns them with the entire HPV16 sequence. The results are sorted by SAM tools [<xref ref-type="bibr" rid="CR26">26</xref>] and annotated by StringTie [<xref ref-type="bibr" rid="CR27">27</xref>]. This step determines whether the sample is positive for HPV16. If the sample is determined to be positive for HPV16, it is annotated using the file that includes E6* (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). The resulting output file will contain FPKM values of HPV16 oncogenes, which can be used to estimate oncogenes expression levels (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Flowchart of DisV-HPV16 Pipeline. The workflow to obtain HPV16 oncogenes expression from RNA sequencing data</p></caption><graphic xlink:href="12879_2019_4123_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>Cell culture and RNA extraction</title>
      <p id="Par15">The head and neck cancer cell line SCC47 was kindly provided by Prof. Henning Willers (Harvard University). The cervical cancer cell line SIHA was maintained in our laboratory. Cells were grown in DMEM, 10% FBS, 100 units/mL penicillin and streptomycin at 37 °C in a humidified incubator, 5% CO<sub>2</sub>. For storage, cells were preserved in liquid N<sub>2</sub> (− 180 °C). Total RNA (1–5 μg) obtained from SIHA and SCC47 cell cultures using Trizol was used for RT-PCR and RNA sequencing.</p>
    </sec>
    <sec id="Sec6">
      <title>RT-PCR</title>
      <p id="Par16">Total RNA (1–5 μg) was reverse transcribed into cDNA using the First strand cDNA kit (Qiagen) according to the manufacturer’s instructions. Total cDNA from HPV16-positive cell lines was amplified using Light-Cycler-FastStart DNA MasterSYBR Green I (TaKaRa Biotechnology, Dalian, China) and HPV16 primers [<xref ref-type="bibr" rid="CR28">28</xref>]. mRNA expression was normalized using the 2<sup>-ΔΔCt</sup> method based on threshold cycle value (CT value).</p>
    </sec>
    <sec id="Sec7">
      <title>RNA sequencing</title>
      <p id="Par17">After total RNA extraction and DNase I treatment, mRNA was isolated using Oligo(dT)-magnetic beads. Libraries were pair-end sequenced using Illumina HiSeqTM4000 by BGI (the Beijing Genomics Institute). The data were transferred into sequencing data via base calling, defined as raw data or raw reads and saved as FASTQ files.</p>
    </sec>
    <sec id="Sec8">
      <title>Oncogenes expression analysis</title>
      <p id="Par18">A heatmap was constructed using the pheatmap package of R. Cluster analysis was performed using R. HPV16 oncogenes expression levels were standardized by calculating the log<sub>10</sub> of FPKM values.</p>
    </sec>
  </sec>
  <sec id="Sec9">
    <title>Results and discussion</title>
    <p id="Par19">We compared DisV-HPV16 with VirusSeq and ViromeScan, two previously available tools for the detection of viruses using data from RNA sequencing. VirusSeq required more time (2 h) than ViromeScan or DisV-HPV16 (1 h) to detect virus in RNA sequencing data from cell lines. In analyzing RNA sequencing data from the human transcriptome, the time differential was considerably greater, with VirusSeq requiring more than one day while DisV-HPV16 requiring the least time (1 h). These differences are summarized in Table <xref rid="Tab1" ref-type="table">1</xref>. We ran the three software tools using the same configuration of CPU. DisV-HPV16 was overall faster in detecting virus in either cell line or human transcriptome RNA sequencing data, which we suggest is attributable to the pipeline design of DisV-HPV16 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Difference in detection time of three softwares</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Sample</th><th rowspan="2">Technology</th><th rowspan="2">#CPU</th><th colspan="3">Detection Time</th></tr><tr><th>VirusSeq</th><th>ViromeScan</th><th>Dis-HPV16</th></tr></thead><tbody><tr><td>Cellline</td><td>RNA-Seq</td><td char="." align="char">8</td><td>&lt; 2 h</td><td>&lt; 1 h</td><td>&lt; 1 h</td></tr><tr><td>Human genome</td><td>RNA-Seq</td><td char="." align="char">8</td><td>&gt; 1 day</td><td>&lt; 1 h</td><td>&lt; 1 h</td></tr></tbody></table><table-wrap-foot><p>Comparing with VirusSeq and ViromeScan, DisV-HPV16 needs less time under the same configuration of CPU</p></table-wrap-foot></table-wrap></p>
    <p id="Par20">DisV-HPV16 detected HPV16 in SIHA cell line RNA sequencing data. Changing the DisV-HPV16 reference file allowed HPV18 detection in HELA cell line data. Furthermore, DisV-HPV16 evaluated the ratio of E2/E6 in HELA (0.007 or 0.002) and SIHA (0.24) cell line data (Table <xref rid="Tab2" ref-type="table">2</xref>). Previous studies have shown that an E2/E6 ratio between 0 and 1 indicates a combined episomal plus integrated HPV16 status, while an E2/E6 ratio of 0 indicates an integrated viral status [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Comparison of software accuracy and function</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Cellline</th><th colspan="3">HPV Genotype Detection</th><th colspan="3">Ratio (E2/E6)</th></tr><tr><th>VirusSeq</th><th>ViromeScan</th><th>DisV-HPV16</th><th>VirusSeq</th><th>ViromeScan</th><th>DisV-HPV16</th></tr></thead><tbody><tr><td>HELA</td><td>HPV18</td><td>HPV18</td><td>HPV18</td><td>–</td><td>–</td><td>0.007</td></tr><tr><td>HELA</td><td>HPV18</td><td>HPV18</td><td>HPV18</td><td>–</td><td>–</td><td>0.002</td></tr><tr><td>SIHA</td><td>HPV16</td><td>HPV16</td><td>HPV16</td><td>–</td><td>–</td><td>0.24</td></tr></tbody></table><table-wrap-foot><p>The bars denote negative results</p></table-wrap-foot></table-wrap></p>
    <p id="Par21">RNA sequencing data from 18 HNSC patients were used to confirm the accuracy and sensitivity of DisV-HPV16. HPV was detected in each of 14 HPV16-positive patient samples by DisV-HPV16, as well as two samples, SRR2932838 and SRR2932841, from HPV35- and HPV33-positive patients, respectively. After changing the DisV-HPV16 reference file, we detected HPV35 in SRR2932838 and HPV33 in SRR2932841 (Table <xref rid="Tab3" ref-type="table">3</xref>). DisV-HPV16 exhibited greater sensitivity than either VirusSeq or ViromeScan in detecting HPV16. We suggest that the enhanced sensitivity may be due to the new reference file we created (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Other genotypes of HPV were detected after changing reference files. Detection of HPV16 in HPV35-positive SRR2932838 and HPV33-positive SRR2932841 indicates the possible occurrence of co-infection in HPV-related cancers, and illustrates the sensitivity and versatility of DisV-HPV16. Previous studies have reported human co-infection by different viruses (e.g. HIV plus HPV) [<xref ref-type="bibr" rid="CR32">32</xref>] as well as different HPV genotypes (the most frequent were HPV6, 16, 42 and 51) [<xref ref-type="bibr" rid="CR33">33</xref>]. HIV infection is known to have a significant impact on HPV genital infection [<xref ref-type="bibr" rid="CR32">32</xref>]. No preferential distribution of specific HPV type(s) with co-infection was identified [<xref ref-type="bibr" rid="CR33">33</xref>]. In the future, such information may be highly useful in designing vaccination campaigns.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Comparison of sensitivity in detection of HPV 16 from different samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Subtype of HPV (n)</th><th rowspan="2">Sample</th><th colspan="3">Software</th></tr><tr><th>VirusSeq</th><th>ViromeScan</th><th>DisV-HPV16</th></tr></thead><tbody><tr><td rowspan="14">HPV16 (14)</td><td>SRR2932830</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932831</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932832</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932833</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932834</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932835</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932839</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932840</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932842</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932843</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932844</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932845</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932846</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>SRR2932847</td><td>Over time</td><td>HPV16</td><td>HPV16</td></tr><tr><td>HPV18 (1)</td><td>SRR2932837</td><td>Over time</td><td>HPV18</td><td>HPV18</td></tr><tr><td>HPV33 (1)</td><td>SRR2932841</td><td>Over time</td><td>HPV33</td><td>HPV16/HPV33</td></tr><tr><td rowspan="2">HPV35 (2)</td><td>SRR2932836</td><td>Over time</td><td>HPV35</td><td>HPV35</td></tr><tr><td>SRR2932838</td><td>Over time</td><td>HPV35</td><td>HPV16/HPV35</td></tr></tbody></table><table-wrap-foot><p>DisV-HPV16 exhibited greater sensitivity than either VirusSeq or ViromeScan in detecting HPV16</p></table-wrap-foot></table-wrap></p>
    <p id="Par22">DisV-HPV16 accuracy was experimentally verified by RT-PCR and RNA sequencing of two HNSC cell lines, SIHA and SCC47. For SIHA cells, similar E7/E6 ratio values of 2 (average CT value: E6 = 21.27, E7 = 20.27) and 2.68 (E7 = 1,049,631.5, E6 = 391,666.94) were obtained using RT-PCR and DisV-HPV16, respectively. In SCC47 cells, RT-PCR and DisV-HPV16 analyses yielded E7/E6 values of 1.74 (average CT value: E6 = 21.73, E7 = 20.93) and 2.26 (E7 = 1,378,347.625, E6 = 610,878.63), respectively (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). These results confirm the reliability and effectiveness of DisV-HPV16 in detecting and evaluating HPV16 oncogenes.<fig id="Fig3"><label>Fig. 3</label><caption><p>Experimental verification of DisV-HPV16 in SIHA and SCC47. <bold>a</bold>The ratio of E6/E7 in SIHA and SCC47 elevated by DisV-HPV16; <bold>b</bold> The radio of E6/E7 in SIHA and SCC47 verified by RT-PCR. The RT-PCR ratio is calculated by CT value</p></caption><graphic xlink:href="12879_2019_4123_Fig3_HTML" id="MO3"/></fig></p>
    <p id="Par23">DisV-HPV16 was used to evaluate HPV16 oncogenes expression in RNA sequencing data from 14 HPV16-positive patients. In a given patient sample the expression levels of different oncogenes were found to vary, as did expression of a given oncogenes among different samples. These observations are summarized in Table <xref rid="Tab4" ref-type="table">4</xref>. Expression levels of HPV16 oncogenes could be clearly depicted in a heatmap based on the FPKM value for each oncogenes (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The 14 samples segment into two groups <bold>(</bold>four on the left and ten on the right in Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Three early genes E6, E7 and E6* are in one cluster while E2, E5 and E1^E4 are in the other, indicating opposite oncogenes expression trends in the two clusters. This result might reflect E2-induced increase in viral replication via splicing-related activities [<xref ref-type="bibr" rid="CR34">34</xref>], which results in high-level expression of E6 and E7. This may result in clinically significant differences among individual patients suffering from HPV16-positive head and neck cancers.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Expression levels of HPV16 oncogenes in 14 HPV16-positive samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Samples</th><th>E1</th><th>E1^E4</th><th>E2</th><th>E5</th><th>L2</th><th>L1</th><th>E6*</th><th>E6</th><th>E7</th></tr></thead><tbody><tr><td>SRR2932830</td><td>4.69</td><td>5.52</td><td>5.55</td><td>5.78</td><td>3.11</td><td>3.44</td><td>5.31</td><td>5.26</td><td>5.66</td></tr><tr><td>SRR2932831</td><td>4.65</td><td>0.00</td><td>0.00</td><td>3.17</td><td>2.21</td><td>2.96</td><td>5.71</td><td>5.82</td><td>6.23</td></tr><tr><td>SRR2932832</td><td>4.72</td><td>5.90</td><td>5.30</td><td>5.76</td><td>4.02</td><td>4.90</td><td>4.61</td><td>5.11</td><td>5.46</td></tr><tr><td>SRR2932833</td><td>4.78</td><td>5.89</td><td>5.35</td><td>5.85</td><td>3.82</td><td>4.36</td><td>5.18</td><td>5.14</td><td>5.51</td></tr><tr><td>SRR2932834</td><td>4.75</td><td>5.93</td><td>5.37</td><td>5.85</td><td>3.67</td><td>3.49</td><td>4.91</td><td>5.17</td><td>5.58</td></tr><tr><td>SRR2932835</td><td>4.64</td><td>5.96</td><td>5.34</td><td>5.90</td><td>3.30</td><td>3.81</td><td>5.13</td><td>5.11</td><td>5.59</td></tr><tr><td>SRR2932839</td><td>4.59</td><td>5.94</td><td>5.35</td><td>5.81</td><td>3.52</td><td>3.81</td><td>5.31</td><td>5.19</td><td>5.68</td></tr><tr><td>SRR2932840</td><td>4.57</td><td>4.58</td><td>5.54</td><td>6.00</td><td>2.61</td><td>3.54</td><td>5.31</td><td>5.26</td><td>5.69</td></tr><tr><td>SRR2932842</td><td>4.74</td><td>5.85</td><td>5.33</td><td>5.81</td><td>3.90</td><td>4.31</td><td>5.28</td><td>5.27</td><td>5.64</td></tr><tr><td>SRR2932843</td><td>4.40</td><td>4.94</td><td>5.28</td><td>5.68</td><td>3.48</td><td>3.75</td><td>5.95</td><td>5.50</td><td>5.99</td></tr><tr><td>SRR2932844</td><td>5.08</td><td>0.00</td><td>3.01</td><td>3.15</td><td>0.00</td><td>3.32</td><td>5.85</td><td>5.66</td><td>6.16</td></tr><tr><td>SRR2932845</td><td>3.21</td><td>0.00</td><td>2.93</td><td>0.00</td><td>0.00</td><td>0.00</td><td>6.00</td><td>5.73</td><td>6.29</td></tr><tr><td>SRR2932846</td><td>4.31</td><td>5.76</td><td>5.46</td><td>6.01</td><td>3.06</td><td>3.61</td><td>5.22</td><td>5.11</td><td>5.62</td></tr><tr><td>SRR2932847</td><td>4.71</td><td>5.88</td><td>5.34</td><td>5.81</td><td>3.15</td><td>3.18</td><td>5.37</td><td>5.27</td><td>5.70</td></tr></tbody></table><table-wrap-foot><p>Note: Standardized numerical value represented expression levels of HPV16 oncogenes</p></table-wrap-foot></table-wrap><fig id="Fig4"><label>Fig. 4</label><caption><p>Heatmap of expression level of oncogenes in 14 HPV16 positive HNSC samples. The cell color based on the FPKM value of HPV16 oncogenes. Red means high expression while blue means low expression</p></caption><graphic xlink:href="12879_2019_4123_Fig4_HTML" id="MO4"/></fig></p>
  </sec>
  <sec id="Sec10">
    <title>Conclusions</title>
    <p id="Par24">The new DisV-HPV16 software not only detected the existence of distinct HPV genotypes (HPV16, HPV18, HPV33 and HPV35) in RNA sequencing data (simply by changing reference files) but also revealed the expression levels of HPV16 oncogenes. DisV-HPV16 provides enhanced virus detection and analysis capabilities based on RNA sequencing data and also enlarges the potential for understanding the effects of viral genes on the host genome and elucidating key features of the virus-host relationship. In the present study we tested DisV-HPV16 on four HPV genotypes. Whether the software can be of value for detection and evaluation of additional viruses will be determined in future studies.</p>
    <sec id="Sec11">
      <title>Availability and requirements</title>
      <p id="Par25">Project name: DisV-HPV16.</p>
      <p id="Par26">Project home page: <ext-link ext-link-type="uri" xlink:href="https://github.com/ybq1204/DisV-HPV16">https://github.com/ybq1204/DisV-HPV16</ext-link></p>
      <p id="Par27">Operating system(s): Linux.</p>
      <p id="Par28">Programming language: Shell.</p>
      <p id="Par29">Other requirements: None.</p>
      <p id="Par30">License: None.</p>
      <p id="Par31">Any restrictions to use by non-academics: None.</p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>CC</term>
        <def>
          <p id="Par4">Cervical carcinoma</p>
        </def>
      </def-item>
      <def-item>
        <term>DisV-HPV16</term>
        <def>
          <p id="Par5">Discover Virus of HPV16</p>
        </def>
      </def-item>
      <def-item>
        <term>HNSC</term>
        <def>
          <p id="Par6">Head and neck squamous carcinoma</p>
        </def>
      </def-item>
      <def-item>
        <term>HPV</term>
        <def>
          <p id="Par7">Human papillomavirus</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We also thank Yu Tong in Nanjing Decode Genomics for his guidance on software usage. We gratefully thank Wu Lien-Ten Institute for providing the computational server which was used in raw data analysis.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>Conceived and designed the experiments: LLW and YZ. Performed the experiments: HHX, FJT, SWZ, BQY. Analyzed the data: BQY, XYL and LHS. English Writing: BQY, SYY and SWZ. All authors approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This study was supported by the Natural Science Foundation of China (81672670 and 81501737) and Heilongjiang province outstanding youth foundation (jc2018023). The funding pay for RNA sequencing and experiment material.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Head and neck cancer sequencing data are downloaded from NCBI database (SRP066090, SRR1021009, SRR540252 and SRR629571). SCC47 was kindly provided by Prof. Henning Willers (Harvard University). The cervical cancer cell line SIHA was maintained in our laboratory. And the sequencing data of cell lines are available.</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p id="Par32">Not applicable.</p>
  </notes>
  <notes>
    <title>Consent for publication</title>
    <p id="Par33">Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par34">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Global Burden of Disease Cancer, C., et al.</collab>
        </person-group>
        <article-title>The global burden of Cancer 2013</article-title>
        <source>JAMA Oncol</source>
        <year>2015</year>
        <volume>1</volume>
        <issue>4</issue>
        <fpage>505</fpage>
        <lpage>527</lpage>
        <pub-id pub-id-type="doi">10.1001/jamaoncol.2015.0735</pub-id>
        <pub-id pub-id-type="pmid">26181261</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moore</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Why do viruses cause cancer? Highlights of the first century of human tumour virology</article-title>
        <source>Nat Rev Cancer</source>
        <year>2010</year>
        <volume>10</volume>
        <issue>12</issue>
        <fpage>878</fpage>
        <lpage>889</lpage>
        <pub-id pub-id-type="doi">10.1038/nrc2961</pub-id>
        <pub-id pub-id-type="pmid">21102637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chrisofos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Skolarikos</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lazaris</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bogris</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Deliveliotis</surname>
            <given-names>Ch</given-names>
          </name>
        </person-group>
        <article-title>HPV 16/18-associated condyloma acuminatum of the urinary bladder: first international report and review of literature</article-title>
        <source>International Journal of STD &amp; AIDS</source>
        <year>2004</year>
        <volume>15</volume>
        <issue>12</issue>
        <fpage>836</fpage>
        <lpage>838</lpage>
        <pub-id pub-id-type="doi">10.1258/0956462042563783</pub-id>
        <pub-id pub-id-type="pmid">15601491</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Syrjanen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rautava</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Syrjanen</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>HPV in Head and Neck Cancer-30 Years of History</article-title>
        <source>Recent Results Cancer Res</source>
        <year>2017</year>
        <volume>206</volume>
        <fpage>3</fpage>
        <lpage>25</lpage>
        <pub-id pub-id-type="doi">10.1007/978-3-319-43580-0_1</pub-id>
        <pub-id pub-id-type="pmid">27699526</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <mixed-citation publication-type="other">Gissmann LU, et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol. 1982:393–400.</mixed-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Spence</surname>
            <given-names>Tara</given-names>
          </name>
          <name>
            <surname>Bruce</surname>
            <given-names>Jeff</given-names>
          </name>
          <name>
            <surname>Yip</surname>
            <given-names>Kenneth</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Fei-Fei</given-names>
          </name>
        </person-group>
        <article-title>HPV Associated Head and Neck Cancer</article-title>
        <source>Cancers</source>
        <year>2016</year>
        <volume>8</volume>
        <issue>8</issue>
        <fpage>75</fpage>
        <pub-id pub-id-type="doi">10.3390/cancers8080075</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Villiers</surname>
            <given-names>EM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Classification of papillomaviruses</article-title>
        <source>Virology</source>
        <year>2004</year>
        <volume>324</volume>
        <issue>1</issue>
        <fpage>17</fpage>
        <lpage>27</lpage>
        <pub-id pub-id-type="doi">10.1016/j.virol.2004.03.033</pub-id>
        <pub-id pub-id-type="pmid">15183049</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ghittoni</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Role of human papillomaviruses in carcinogenesis</article-title>
        <source>Ecancermedicalscience</source>
        <year>2015</year>
        <volume>9</volume>
        <fpage>526</fpage>
        <pub-id pub-id-type="doi">10.3332/ecancer.2015.526</pub-id>
        <pub-id pub-id-type="pmid">25987895</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dayyani</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)</article-title>
        <source>Head Neck Oncol</source>
        <year>2010</year>
        <volume>2</volume>
        <fpage>15</fpage>
        <pub-id pub-id-type="doi">10.1186/1758-3284-2-15</pub-id>
        <pub-id pub-id-type="pmid">20587061</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sung</surname>
            <given-names>WK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma</article-title>
        <source>Nat Genet</source>
        <year>2012</year>
        <volume>44</volume>
        <issue>7</issue>
        <fpage>765</fpage>
        <lpage>769</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2295</pub-id>
        <pub-id pub-id-type="pmid">22634754</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stransky</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The mutational landscape of head and neck squamous cell carcinoma</article-title>
        <source>Science</source>
        <year>2011</year>
        <volume>333</volume>
        <issue>6046</issue>
        <fpage>1157</fpage>
        <lpage>1160</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1208130</pub-id>
        <pub-id pub-id-type="pmid">21798893</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients</article-title>
        <source>Genome Res</source>
        <year>2012</year>
        <volume>22</volume>
        <issue>4</issue>
        <fpage>593</fpage>
        <lpage>601</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.133926.111</pub-id>
        <pub-id pub-id-type="pmid">22267523</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue</article-title>
        <source>Bioinformatics</source>
        <year>2013</year>
        <volume>29</volume>
        <issue>2</issue>
        <fpage>266</fpage>
        <lpage>267</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts665</pub-id>
        <pub-id pub-id-type="pmid">23162058</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>VirusFinder: software for efficient and accurate detection of viruses and their integration sites in host genomes through next generation sequencing data</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <issue>5</issue>
        <fpage>e64465</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0064465</pub-id>
        <pub-id pub-id-type="pmid">23717618</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rampelli</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ViromeScan: a new tool for metagenomic viral community profiling</article-title>
        <source>BMC Genomics</source>
        <year>2016</year>
        <volume>17</volume>
        <fpage>165</fpage>
        <pub-id pub-id-type="doi">10.1186/s12864-016-2446-3</pub-id>
        <pub-id pub-id-type="pmid">26932765</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nooij</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Overview of virus metagenomic classification methods and their biological applications</article-title>
        <source>Front Microbiol</source>
        <year>2018</year>
        <volume>9</volume>
        <fpage>749</fpage>
        <pub-id pub-id-type="doi">10.3389/fmicb.2018.00749</pub-id>
        <pub-id pub-id-type="pmid">29740407</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bushman</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide analysis of retroviral DNA integration</article-title>
        <source>Nat Rev Microbiol</source>
        <year>2005</year>
        <volume>3</volume>
        <issue>11</issue>
        <fpage>848</fpage>
        <lpage>858</lpage>
        <pub-id pub-id-type="doi">10.1038/nrmicro1263</pub-id>
        <pub-id pub-id-type="pmid">16175173</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Viral carcinogenesis: factors inducing DNA damage and virus integration</article-title>
        <source>Cancers (Basel)</source>
        <year>2014</year>
        <volume>6</volume>
        <issue>4</issue>
        <fpage>2155</fpage>
        <lpage>2186</lpage>
        <pub-id pub-id-type="doi">10.3390/cancers6042155</pub-id>
        <pub-id pub-id-type="pmid">25340830</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>French</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway</article-title>
        <source>Mol Cancer</source>
        <year>2013</year>
        <volume>12</volume>
        <fpage>38</fpage>
        <pub-id pub-id-type="doi">10.1186/1476-4598-12-38</pub-id>
        <pub-id pub-id-type="pmid">23651589</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruttkay-Nedecky</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins. (Review)</article-title>
        <source>Int J Oncol</source>
        <year>2013</year>
        <volume>43</volume>
        <issue>6</issue>
        <fpage>1754</fpage>
        <lpage>1762</lpage>
        <pub-id pub-id-type="doi">10.3892/ijo.2013.2105</pub-id>
        <pub-id pub-id-type="pmid">24045364</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>M</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>L</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>D</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Human papillomavirus-related diseases of the female lower genital tract: oncogenic aspects and molecular interaction</article-title>
        <source>%A Zekan J Collegium antropologicum</source>
        <year>2014</year>
        <volume>38</volume>
        <issue>2</issue>
        <fpage>779</fpage>
        <lpage>786</lpage>
        <pub-id pub-id-type="pmid">25145023</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wise-Draper</surname>
            <given-names>Trisha, M.</given-names>
          </name>
        </person-group>
        <article-title>Papillomavirus E6 and E7 proteins and their cellular targets</article-title>
        <source>Frontiers in Bioscience</source>
        <year>2008</year>
        <volume>13</volume>
        <issue>13</issue>
        <fpage>1003</fpage>
        <pub-id pub-id-type="doi">10.2741/2739</pub-id>
        <pub-id pub-id-type="pmid">17981607</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>Zhi-Ming</given-names>
          </name>
        </person-group>
        <article-title>Papillomavirus genome structure, expression, and post-transcriptional regulation</article-title>
        <source>Frontiers in Bioscience</source>
        <year>2006</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>2286</fpage>
        <pub-id pub-id-type="doi">10.2741/1971</pub-id>
        <pub-id pub-id-type="pmid">16720315</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures</article-title>
        <source>Clin Cancer Res</source>
        <year>2016</year>
        <volume>22</volume>
        <issue>18</issue>
        <fpage>4735</fpage>
        <lpage>4745</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-0323</pub-id>
        <pub-id pub-id-type="pmid">27091409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Langmead</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Salzberg</surname>
            <given-names>SL</given-names>
          </name>
        </person-group>
        <article-title>HISAT: a fast spliced aligner with low memory requirements</article-title>
        <source>Nat Methods</source>
        <year>2015</year>
        <volume>12</volume>
        <issue>4</issue>
        <fpage>357</fpage>
        <lpage>360</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id>
        <pub-id pub-id-type="pmid">25751142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The sequence alignment/map format and SAMtools</article-title>
        <source>Bioinformatics</source>
        <year>2009</year>
        <volume>25</volume>
        <issue>16</issue>
        <fpage>2078</fpage>
        <lpage>2079</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
        <pub-id pub-id-type="pmid">19505943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pertea</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>StringTie enables improved reconstruction of a transcriptome from RNA-seq reads</article-title>
        <source>Nat Biotechnol</source>
        <year>2015</year>
        <volume>33</volume>
        <issue>3</issue>
        <fpage>290</fpage>
        <lpage>295</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.3122</pub-id>
        <pub-id pub-id-type="pmid">25690850</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes</article-title>
        <source>Carcinogenesis</source>
        <year>2014</year>
        <volume>35</volume>
        <issue>10</issue>
        <fpage>2373</fpage>
        <lpage>2381</lpage>
        <pub-id pub-id-type="doi">10.1093/carcin/bgu156</pub-id>
        <pub-id pub-id-type="pmid">25064354</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arias-Pulido</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer</article-title>
        <source>J Clin Microbiol</source>
        <year>2006</year>
        <volume>44</volume>
        <issue>5</issue>
        <fpage>1755</fpage>
        <lpage>1762</lpage>
        <pub-id pub-id-type="doi">10.1128/JCM.44.5.1755-1762.2006</pub-id>
        <pub-id pub-id-type="pmid">16672403</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Badaracco</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness</article-title>
        <source>J Med Virol</source>
        <year>2002</year>
        <volume>67</volume>
        <issue>4</issue>
        <fpage>574</fpage>
        <lpage>582</lpage>
        <pub-id pub-id-type="doi">10.1002/jmv.10141</pub-id>
        <pub-id pub-id-type="pmid">12116007</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Si</surname>
            <given-names>HX</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Physical status of HPV-16 in esophageal squamous cell carcinoma</article-title>
        <source>J Clin Virol</source>
        <year>2005</year>
        <volume>32</volume>
        <issue>1</issue>
        <fpage>19</fpage>
        <lpage>23</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jcv.2004.04.004</pub-id>
        <pub-id pub-id-type="pmid">15572001</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mbulawa</surname>
            <given-names>ZZ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection</article-title>
        <source>J Infect Dis</source>
        <year>2009</year>
        <volume>199</volume>
        <issue>10</issue>
        <fpage>1514</fpage>
        <lpage>1524</lpage>
        <pub-id pub-id-type="doi">10.1086/598220</pub-id>
        <pub-id pub-id-type="pmid">19392625</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Freire</surname>
            <given-names>MP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genital prevalence of HPV types and co-infection in men</article-title>
        <source>Int Braz J Urol</source>
        <year>2014</year>
        <volume>40</volume>
        <issue>1</issue>
        <fpage>67</fpage>
        <lpage>71</lpage>
        <pub-id pub-id-type="doi">10.1590/S1677-5538.IBJU.2014.01.10</pub-id>
        <pub-id pub-id-type="pmid">24642151</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Graham</surname>
            <given-names>SV</given-names>
          </name>
          <name>
            <surname>Faizo</surname>
            <given-names>AAA</given-names>
          </name>
        </person-group>
        <article-title>Control of human papillomavirus gene expression by alternative splicing</article-title>
        <source>Virus Res</source>
        <year>2017</year>
        <volume>231</volume>
        <fpage>83</fpage>
        <lpage>95</lpage>
        <pub-id pub-id-type="doi">10.1016/j.virusres.2016.11.016</pub-id>
        <pub-id pub-id-type="pmid">27867028</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
